Navigation Links
Chemo Pills Effective, But Patients May Skip Doses
Date:1/17/2013

THURSDAY, Jan. 17 (HealthDay News) -- Although chemotherapy pills are able to target certain cancers better than traditional intravenous drugs, some patients have trouble taking them, according to new research.

A study from researchers at Michigan State University found that more than 40 percent of patients took the wrong number of pills or skipped doses altogether. They noted severe side effects and complicated instructions for some oral prescriptions often are to blame.

"Prescriptions for some oral pills have complex instructions," study leader Sandra Spoelstra, an assistant professor of nursing, said in a university news release. "Some of them require patients to take pills several times a day or cycle their doses, taking one pill a day for three weeks, then stopping for a week before starting again. And some patients take two types of pills to treat their cancer or have multiple medications for other chronic conditions. It can be very complicated."

The researchers noted that chemotherapy pills often cause pain, severe nausea, vomiting, diarrhea, fatigue and skin reactions. Patients may skip doses of their medications to avoid these negative side effects, making the pills ineffective.

In the study, which was published recently in the journal Cancer Nursing, the researchers divided the participants into three groups. The first group included patients who had help deciphering their prescriptions from an automated calling system developed at the university. Patients in the second group received the automated calls as well as follow-up calls from nurses providing them with tips on how to stick to their treatment plan. The third group received the automated calls and the follow-up tips from nurses, as well as advice on how to manage their symptoms.

The study found that patients in all three groups said their symptoms had eased by the end of the study. The researchers noted that the automated calls alone were just as effective as when they were offered with tips from nurses.

The study's authors concluded that the automated call system could be an inexpensive way to help patients on chemotherapy pills follow through on their treatment plan correctly. They said nurses should carefully explain oral chemotherapy instructions. The researchers added that their findings could provide a foundation for more research to help improve oral chemotherapy.

"It's cutting-edge treatment, but we don't know enough about it yet," said the study's co-author, Barbara Given, associate dean for research in the university's College of Nursing. "People think if they had a life-threatening disease and their doctor recommended treatment, they'd follow the recommendations. But it's really not that simple."

More information

The U.S. National Cancer Institute provides more information on cancer drugs.

-- Mary Elizabeth Dallas

SOURCE: Michigan State University, news release, Jan. 10, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New model may help predict response to chemotherapy for colorectal cancer
2. Paired CT scans catch chemo-killing of liver tumors in real time
3. UAlberta medical researchers discover new potential chemotherapy
4. Intensified chemotherapy shows promise for children with very high risk form of leukemia
5. UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy
6. Chemo Brain May Occur Before Treatment Even Starts
7. For Aggressive Breast Cancer, Chemo May Work Better in the Young
8. Immune system kill switch could be target for chemotherapy and infection recovery
9. Chemo May Extend Survival After Breast Cancers Return
10. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
11. Improving chemotherapy effectiveness by acting on the immune system
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo Pills Effective, But Patients May Skip Doses
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: